Table 4 Laboratory findings and previous antimalarial use reported per RDT outcome
Characteristics | n/N (%) |
|---|---|
False malaria positive | 141 |
Laboratory data | |
Alternative cause of fever | 36/141 (25.5) |
Bacterial bloodstream infection (BSI) | 23/141 (16.3) |
Rotavirus/adenovirus | 9/141 (6.4) |
Urinary tract infection (UTI) | 6/141 (4.3) |
Previous antimalarial use reported | 14/141 (9.9) |
True malaria negative | 202 |
Laboratory data | |
Alternative cause of fever | 26/202 (12.9) |
Bloodstream infection (BSI) | 12/202 (5.9) |
Rotavirus/adenovirus | 13/202 (6.4) |
Urinary tract infection (UTI) | 01/202 (0.5) |
Previous antimalarial use reported | 19/202 (9.4) |
True malaria positive | 334 |
Laboratory data | |
Alternative cause of fever | 11/334 (3.3) |
Bloodstream infection (BSI) | 06/334 (1.8) |
Rotavirus/adenovirus | 03/334 (0.9) |
Urinary tract infection (UTI) | 03/334 (0.9) |
Previous antimalarial use reported | 01/334 (0.3) |